Surface Oncology Appoints Carsten Brunn to Board of Directors

GlobeNewswire Jun 29 2022 BoardMoves

Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Carsten Brunn, Ph.D., will join the company’s board of directors...

Read Full Article

Bookmark or Share this article

Login to comment.

Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
Diverse Slate of Corporate Directors Become NACD Fellows - GlobeNewswire also published in GlobeNewswire

Surface Oncology Appoints Carsten Brunn to Board of Directors

Login to comment.

Related Articles

Topics Mentioned

Surface Oncology Appoints Carsten Brunn to Board of Directors

Login to comment.

Related Articles

Categories

BoardProspects Features:

Topics Mentioned